Stem Cells used for advanced COVid-19 patients

Holy Name Hospital in Teaneck NJ started treating a critically ill coronavirus patient with placental stem cells.

4/11/2020
httpwww.nj.com/coronavirus/2020/04/nj-hospital-tries-experimental-placenta-therapy-on-critically-ill-coronavirus-patient.htmls://www.nj.com/coronavirus/2020/04/nj-hospital-tries-experimental-placenta-therapy-on-critically-ill-coronavirus-patient.html
​

---

According to a report in the DailMail.com Dr. Doncheng Wu who runs a lab in Wuhan China where the COVID-19 coronavirus was first reported was able to successfully treat 9 hospitalized patients with coronavirus pneumonia. The patients were treated with intravenous umbilical cord mesenchymal stem cells all 9 patients survived and made a complete recovery within days of treatment. 1 patient who was on the verge of being intubated was reported to be ambulating 2 days later. 
-H. William Song, MD 4/5/2020

---

According to a New York TImes report on April 2, 2020, a New Jersey Company called Celularity will be conducting an clinical trial of human placenta derived stem cell treatment on hospitalized Coronavirus patients to see if the treatment will help prevent progression of the illness. 
​-H. William Song, MD 4/6/2020

---

On May 20, 2020 a New Jersey hospital ,Doctor Douglas Spiel orchestrated the first treatment of an ARDS patient ( presumed covid- 19 infection) with MSC placental exosomes in the world. 20 billion exosomes from Kimera labs were introduced intravenously shortly after emergent intubation. In 12 hours, the arterial blood gas oxygenation changed from 147 to 350 signifying miraculous improvement of gas exchange in lung tissue filled with inflammatory fluid.
Coronavirus leads to an upregulation
of inflammation yielding leaky vessels , subsequent adult respiratory distress syndrome and death. This is called a cytokine storm. Preliminary evidence suggests that pretreatment and even post treatment with Kimera exosomes will save countless lives.
-H. William Song, MD 4/5/2020